Home Healthcare Drugs Pharmaceutical Drug Delivery Market by Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Topical Drug Delivery, and Others) and Application (Cancer, Diabetes, Respiratory Diseases, Cardiovascular Diseases, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

Pharmaceutical Drug Delivery Market by Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Topical Drug Delivery, and Others) and Application (Cancer, Diabetes, Respiratory Diseases, Cardiovascular Diseases, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

Publisher: Allied Market Research
Publication Date: March, 2020
Healthcare / Drugs
Pages: 216
Delivery Format: PDF

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

The global pharmaceutical drug delivery market accounted for $1,200 million in 2018, and is expected to reach $1,733 million by 2026, registering a CAGR of 4.7% from 2019 to 2026.
Pharmaceutical drug delivery methods enable the introduction of therapeutic agents into the body. These drugs are administered through various routes, and selection of a suitable route of administration is crucial to achieve higher bioavailability at the site of action. Therefore, drug delivery systems are employed to achieve high drug targeting specificity, low systemic drug toxicity, and improved drug absorption rates. Nasal drug delivery system, ocular drug delivery, pulmonary drug delivery, and oral drug delivery system are some of the routes, which are used for drug administration. In addition, these systems are used in treatment of various chronic conditions such as cancer, cardiovascular diseases, and respiratory diseases.

The major factor that contributes to the growth of the global pharmaceutical drug delivery market include surge in awareness related to use of pharmaceutical drug delivery systems. Furthermore, the growth of the market is driven by other factors such as rise in healthcare expenditure and surge in governmental support for research in the field of drug delivery. In addition, surge in prevalence of various chronic diseases, which require the use of pharmaceutical drug delivery is another major factor that contributes toward the growth of the market. However, rise in number of drug recalls and drug failures restricts the growth of the global market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.

The global pharmaceutical drug delivery market is segmented into route of administration, application, and region. On the basis of route of administration, it is categorized into oral drug delivery system, pulmonary drug delivery, ocular drug delivery systems, nasal drug delivery system, ocular drug delivery, topical drug delivery, and others. By application, it is segregated into cancer, diabetes, respiratory diseases, cardiovascular diseases, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA). .

KEY BENEFITS FOR STAKEHOLDERS

• This report entails a detailed quantitative analysis along with the current global pharmaceutical drug delivery systemmarket trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.

• The market size and estimations are based on a comprehensive analysis of key developments in the industry.

• A qualitative analysis based on innovative products facilitates strategic business planning.

• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

• By Route of administration

o Oral drug delivery
o Pulmonary drug delivery
o Injectable drug delivery
o Nasal drug delivery
o Ocular drug delivery
o Topical Drug Delivery
o Others

• By Application

o Cancer
o Diabetes
o Respiratory Diseases
o Cardiovascular Diseases
o Others

• By Region

o North America

§ U.S.
§ Canada
§ Mexico

o Europe

§ Germany
§ France
§ UK
§ Italy
§ Spain
§ Rest of Europe

o Asia-Pacific

§ Japan
§ China
§ India
§ Australia
§ South Korea
§ Rest of Asia-Pacific

o LAMEA

§ Brazil
§ Saudi Arabia
§ South Africa
§ Rest of LAMEA

• List of key players profiled in the report:

• Bayer AG
• Becton, Dickinson And Company
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• 3M Company
• Pfizer Inc.
• Sanofi

LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request)

• Novartis AG
• Antares Pharma, Inc.

Select Plan

1 User License $5,370

5 Users License $6,450

Are you looking for a Consultant?

Email Us

Get a Quote

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$5,370

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed